Continuous venovenous hemodiafiltration in the treatment of newborns with an inborn metabolic disease: a single center experience

CVVHDF is a CRRT modality that can be used to treat newborns with an inborn metabolic disease. Early diagnosis, commencement of specific medical therapy, diet, and extracorporeal support, if needed, are likely to result in improved short and long- term outcomes.